Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs TMED overlap: 47% of top holdings shared

Bottom line

How much do XLV and TMED overlap?

47% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 40.4% of XLV's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVTMED
Weight overlap (top 25)47%
Shared holdings10
Weight in shared holdings40.4%45.5%
Total positions65102
Expense ratio0.08%0.44%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and TMED have in common

Holding% of XLV% of TMEDOverlap
Eli Lilly & Co16.51%16.71%16.51%
UnitedHealth Group Inc6.57%6.52%6.52%
Thermo Fisher Scientific Inc3.24%4.11%3.24%
Gilead Sciences Inc2.73%4.44%2.73%
Intuitive Surgical Inc2.45%2.43%2.43%
Pfizer Inc2.39%1.91%1.91%
Danaher Corp2.09%2.96%2.09%
Stryker Corp1.89%2.22%1.89%
McKesson Corp1.58%1.46%1.46%
Cencora Inc0.96%2.75%0.96%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Johnson & Johnson — 10.64%
  2. AbbVie Inc — 7.74%
  3. Merck & Co Inc — 5.52%
  4. Amgen Inc — 3.40%
  5. Abbott Laboratories — 2.75%
  6. CVS Health Corp — 2.30%
  7. Vertex Pharmaceuticals Inc — 2.19%
  8. Bristol-Myers Squibb Co — 2.05%
  9. Medtronic PLC — 1.75%
  10. Elevance Health Inc — 1.46%
  11. Cigna Group/The — 1.27%
  12. Boston Scientific Corp — 1.10%
  13. Regeneron Pharmaceuticals Inc — 1.08%
  14. HCA Healthcare Inc — 1.05%
  15. Cardinal Health Inc — 0.97%

Only in TMED

  1. Agilent Technologies Inc — 2.61%
  2. Alnylam Pharmaceuticals Inc — 2.60%
  3. Insulet Corp — 2.38%
  4. Dyne Therapeutics Inc — 2.03%
  5. Elanco Animal Health Inc — 1.91%
  6. Cytokinetics Inc — 1.69%
  7. Waters Corp — 1.68%
  8. West Pharmaceutical Services — 1.65%
  9. Ascendis Pharma A/s — 1.60%
  10. Biogen Inc — 1.55%
  11. Dexcom Inc — 1.46%
  12. Immunome Inc — 1.38%
  13. Biontech Se-adr — 1.29%
  14. Humana Inc — 1.24%
  15. Denali Therapeutics Inc — 1.22%

Asset mix

Asset typeXLVTMED
Stocks99.7%99.3%
Cash & short-term funds0.3%0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVTMED
US97.9%93.3%
IE2.1%—
DK—1.6%
DE—1.6%
KY—1.1%
NL—0.9%
CH—0.5%
CA—0.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and TMED overlap?
About 47% by weight. 10 securities appear in both funds' top 25 holdings; they make up 40.4% of XLV's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and TMED have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Gilead Sciences Inc, Intuitive Surgical Inc.
Should I own both XLV and TMED?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or TMED?
TMED is broader, with 102 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.